Share Share Share Skip to PDF content Download PDF Learn more about Non-Animal Navigator™ Certara Non-Animal Navigator™ 解决方案通过以下方式助力企业转型： View Non-Animal Navigator™Contact us 精选推荐 AllModeling and Simulation Semi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy VolunteersSemi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy VolunteersPublicationSemi-Mechanistic Joint Population Pharmacokinetic Modeling of the Novel Antituberculosis Drug Sorfequiline and Its Metabolite M3 in Healthy Volunteers Pharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular DystrophyPharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular DystrophyPosterPharmacometric Analysis of Givinostat to Support Individualized Dosing Recommendations in Pediatric Patients with Duchenne Muscular Dystrophy Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug developmentBeyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug developmentPublicationBeyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development
